PET shows promise for detecting NSCLC recurrence
September 17, 2020 -- F-18 FDG PET/CT shows promise for detecting recurrence of disease in non-small cell lung cancer (NSCLC) patients after they've undergone surgery, according to a study published September 9 in General Thoracic and Cardiovascular Surgery.
Discuss
September 17, 2020 -- F-18 FDG PET/CT shows promise for detecting recurrence of disease in non-small cell lung cancer (NSCLC) patients after they've undergone surgery, according to a study published September 9 in General Thoracic and Cardiovascular Surgery.
Discuss PET/MRI boosts cancer detection
September 17, 2020 -- PET/MRI helps clinicians stage cancer treatment as well as PET/CT -- and finds more than 25% additional cancers, according to a study published in the Journal of Nuclear Medicine. It also reduces overall radiation exposure.
Discuss
September 17, 2020 -- PET/MRI helps clinicians stage cancer treatment as well as PET/CT -- and finds more than 25% additional cancers, according to a study published in the Journal of Nuclear Medicine. It also reduces overall radiation exposure.
Discuss PET helps diagnose treatable form of dementia
September 16, 2020 -- PET imaging could be a useful tool for diagnosis and treatment of idiopathic normal pressure hydrocephalus, a form of dementia that can be treated surgically, according to a literature review published September 7 in the International Journal of Molecular Sciences.
Discuss
September 16, 2020 -- PET imaging could be a useful tool for diagnosis and treatment of idiopathic normal pressure hydrocephalus, a form of dementia that can be treated surgically, according to a literature review published September 7 in the International Journal of Molecular Sciences.
Discuss PET agent shows promise for imaging lung inflammation
September 16, 2020 -- An experimental PET imaging agent shows promise for imaging inflammation in the lungs -- which could have implications for a range of common diseases, including COVID-19, according to results from an animal study published in Redox Biology.
Discuss
September 16, 2020 -- An experimental PET imaging agent shows promise for imaging inflammation in the lungs -- which could have implications for a range of common diseases, including COVID-19, according to results from an animal study published in Redox Biology.
Discuss NIH to fund PET imaging for Latino Alzheimer's study
September 14, 2020 -- The U.S. National Institutes of Health (NIH) has provided additional funding for researchers to use PET imaging to study Alzheimer's disease among Mexican Americans. The funds add amyloid and tau PET imaging to the ongoing Health and Aging Brain Among Latino Elders study.
Discuss
September 14, 2020 -- The U.S. National Institutes of Health (NIH) has provided additional funding for researchers to use PET imaging to study Alzheimer's disease among Mexican Americans. The funds add amyloid and tau PET imaging to the ongoing Health and Aging Brain Among Latino Elders study.
Discuss FET-PET offers more info on treatment of brain metastases
September 14, 2020 -- Using PET with the radiolabeled amino acid F-18 fluoroethyl-tyrosine (F-18 FET) can significantly help determine the efficacy of radiotherapy in certain cancer patients who develop brain metastases, according to a study published online September 4 in the Journal of Nuclear Medicine.
Discuss
September 14, 2020 -- Using PET with the radiolabeled amino acid F-18 fluoroethyl-tyrosine (F-18 FET) can significantly help determine the efficacy of radiotherapy in certain cancer patients who develop brain metastases, according to a study published online September 4 in the Journal of Nuclear Medicine.
Discuss PET radiomics tailor head/neck cancer treatment
September 10, 2020 -- Radiomic factors -- that is, image-based tumor phenotypes -- gleaned from F-18 FDG PET exams can help clinicians personalize care and better predict treatment outcomes for patients with head and neck squamous cell carcinoma, according to a study published September 7 in EJNMMI Research.
Discuss
September 10, 2020 -- Radiomic factors -- that is, image-based tumor phenotypes -- gleaned from F-18 FDG PET exams can help clinicians personalize care and better predict treatment outcomes for patients with head and neck squamous cell carcinoma, according to a study published September 7 in EJNMMI Research.
Discuss Nuclear medicine volume plummets due to COVID-19
September 8, 2020 -- It's no secret COVID-19 has disrupted nuclear medicine clinical practice, research, and work environments. However, a new survey by the Society of Nuclear Medicine and Molecular Imaging quantifies the effects: nearly 80% of respondents saw declines of 50% to 75% in non-PET nuclear medicine procedures.
Discuss
September 8, 2020 -- It's no secret COVID-19 has disrupted nuclear medicine clinical practice, research, and work environments. However, a new survey by the Society of Nuclear Medicine and Molecular Imaging quantifies the effects: nearly 80% of respondents saw declines of 50% to 75% in non-PET nuclear medicine procedures.
Discuss SNMMI updates ventilation study guidance
September 8, 2020 -- The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has updated its statement regarding the use of ventilation/perfusion lung studies during the COVID-19 pandemic to recognize that sometimes these studies are clinically necessary.
Discuss
September 8, 2020 -- The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has updated its statement regarding the use of ventilation/perfusion lung studies during the COVID-19 pandemic to recognize that sometimes these studies are clinically necessary.
Discuss Dual-phase technique improves PET/CT brain tumor imaging
September 3, 2020 -- Using a dual-phase technique with F-18 FDG PET/CT -- that is, performing the exam at two time points after FDG administration -- improves the modality's lesion detection and diagnostic accuracy in malignant brain tumors, according to a study published August 25 in the American Journal of Roentgenology.
Discuss
September 3, 2020 -- Using a dual-phase technique with F-18 FDG PET/CT -- that is, performing the exam at two time points after FDG administration -- improves the modality's lesion detection and diagnostic accuracy in malignant brain tumors, according to a study published August 25 in the American Journal of Roentgenology.
Discuss
Special Feature
Nuclear medicine guidelines promote COVID-19 safety
How can nuclear medicine departments keep patients and staff safe during the COVID-19 pandemic? A new set of guidelines from the IAEA provides some guidance.. Read more
Industry News
VENDOR CONNECT
Conferences
Virtual Vancouver Imaging Review: Head to Toe
September 24-26
Online
September 24-26
Online
American Society of Nuclear Cardiology (ASNC) Annual Scientific Session
September 25-26
Online
September 25-26
Online
World Molecular Imaging Congress (WMIC)
October 7-9
Online
October 7-9
Online
Imaging in the Bahamas
January 18-21, 2021
Nassau, New Providence Bahamas
January 18-21, 2021
Nassau, New Providence Bahamas